Annals of Internal Medicine Podcast · American College of Physicians

Issue Summary January 7, 2025

·14 min·1 clip

Ritatruchide trials showed 21.1% weight loss, terzepatide 17.8%, semaglutide 13.9%, and liraglutide 5.8%.

The host summarizes key new medical research from the Annals of Internal Medicine, covering studies on billing for patient portal messages, anticoagulation dosing for COVID-19, GLP-1 agonists for weight loss, the genetics of yellow nail syndrome, and the threat of predatory journals. It's a rapid-fire overview of evidence-based clinical updates for healthcare professionals.

Listen to the show on

Apple Podcasts Spotify

Play clips from this episode More from Annals of Internal Medicine Podcast